Literature DB >> 9607854

Stability over time of serum antibody levels to human papillomavirus type 16.

V af Geijersstam1, M Kibur, Z Wang, P Koskela, E Pukkala, J Schiller, M Lehtinen, J Dillner.   

Abstract

The stability over time of serum IgG antibody levels to human papillomavirus type 16 (HPV-16) was determined by comparing the HPV-16 capsid antibody levels in serial serum samples of an age-stratified random subsample of 1656 primiparous mothers resident in Helsinki who were followed until their second pregnancy, on average 29.5 months later. The correlation between the first and second pregnancy HPV-16 serum antibody levels of the same woman was high, even when >4 years had elapsed between pregnancies (r = .822). Between negativity, indeterminate results, or quartiles of positivity, the predictive values for being classified in the same category on both occasions ranged between 42% and 91%. Correlation coefficients, predictive values, and kappa coefficients between serial samples all were comparable with those of repeat analyses of the same sample, indicating that HPV capsid antibody levels are generally stable during several years of follow-up.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607854     DOI: 10.1086/517428

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.

Authors:  A Touzé; S de Sanjosé; P Coursaget; M R Almirall; V Palacio; C J Meijer; J Kornegay; F X Bosch
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study).

Authors:  Beibei Lu; Raphael P Viscidi; Ji-Hyun Lee; Yougui Wu; Luisa L Villa; Eduardo Lazcano-Ponce; Roberto J Carvalho da Silva; Maria Luiza Baggio; Manuel Quiterio; Jorge Salmerón; Danelle C Smith; Martha Abrahamsen; Mary Papenfuss; Heather G Stockwell; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-04       Impact factor: 4.254

4.  Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.

Authors:  Mirte Scherpenisse; Rutger M Schepp; Madelief Mollers; Sofie H Mooij; Chris J L M Meijer; Guy A M Berbers; Fiona R M van der Klis
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

Review 5.  Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology.

Authors:  Joan Campbell-Tofte; Aristidis Vrahatis; Knud Josefsen; Jesper Mehlsen; Kaj Winther
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

6.  Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions.

Authors:  Maxime J J Fleury; Antoine Touzé; Silvia de Sanjosé; F Xavier Bosch; Joellen Klaustermeiyer; Pierre Coursaget
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

7.  Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.

Authors:  Jennifer E Cameron; Isaac V Snowhite; Anil K Chaturvedi; Michael E Hagensee
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Human papillomavirus seropositivity and subsequent risk of HIV acquisition in rural South African women.

Authors:  Frank Tanser; Kyle G Jones; Johannes Viljoen; John Imrie; Erofili Grapsa; Marie-Louise Newell
Journal:  Sex Transm Dis       Date:  2013-07       Impact factor: 2.830

9.  Specificity of L1 peptides versus virus-like particles for detection of human papillomavirus-positive cervical lesions in females attending Engativa Hospital, Bogota, Colombia.

Authors:  Mauricio Urquiza; Ricardo Sánchez; Jairo Amaya; Sandra León; Jenny Acosta; Manuel A Patarroyo; Milena Camargo; Manuel E Patarroyo
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

Review 10.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.